SHARE-BASED COMPENSATION (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Share-Based Compensation [Abstract] |
|
| Summary of share-based compensation plans |
|
Common shares outstanding, September 30, 2022
|
111,890,707 |
|
|
| Common shares reserved for issuance: 15% |
16,783,606 |
|
|
Stock options outstanding, September 30, 2022
|
|
(7,426,665 |
)
|
|
RSU outstanding, September 30, 2022
|
|
(5,499,663 |
)
|
|
Common shares reserved for future grants
|
3,857,278 |
|
|
| Summary of granted stock options to acquire common stock |
|
|
2022
|
2021
|
|
|
Stock
Options
|
Weighted
Average
Exercise
Price
|
Stock
Options
|
Weighted
Average
Exercise
Price
|
|
|
|
$
|
|
$
|
|
Balance, January 1
|
5,257,089 |
|
1.73 |
2,923,770 |
|
1.76 |
|
Granted
|
4,755,758 |
|
0.57 |
3,316,195 |
|
1.99 |
|
Forfeited
|
(2,242,337 |
)
|
1.82 |
(19,568 |
)
|
0.73 |
|
Expired
|
(343,845 |
)
|
1.59 |
(84,974 |
)
|
3.58 |
|
Exercised
|
--
|
|
--
|
(352,133 |
)
|
1.71 |
|
Balance, September 30
|
7,426,665 |
|
0.94 |
5,783,290 |
|
1.87 |
|
| Summary of granted restricted share units |
|
|
2022
|
|
2021
|
|
|
Balance at Jan 1
|
1,581,607 |
|
--
|
|
|
Granted
|
4,758,389 |
|
2,253,040 |
|
|
Exercised
|
(702,000 |
)
|
--
|
|
|
Cancelled
|
(132,083 |
)
|
--
|
|
|
Expired
|
(6,250 |
)
|
|
|
|
Balance, September 30
|
5,499,663 |
|
2,253,040 |
|
|
| Summary of stock-based compensation expense |
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
Sept 30, 2022
|
|
Sept 30, 2021
|
|
Sept 30, 2022
|
|
Sept 30, 2021
|
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Stock options
|
|
278 |
|
706 |
|
233 |
|
1,661 |
|
|
RSUs
|
|
637 |
|
595 |
|
1,226 |
|
1,591 |
|
|
Total G&A - Stock options & RSUs
|
|
915 |
|
1,301 |
|
1,459 |
|
3,252 |
|
|
Stock options
|
|
243 |
|
121 |
|
587 |
|
368 |
|
|
RSUs
|
|
88 |
|
-
|
|
88 |
|
-
|
|
|
Total R&D - Stock options & RSUs
|
|
331 |
|
121 |
|
675 |
|
368 |
|
|
Share-based compensation expense
|
|
1,246 |
|
1,422 |
|
2,134 |
|
3,620 |
|
|